Previous close | 58.80 |
Open | 58.80 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 58.80 - 58.80 |
52-week range | 56.80 - 78.20 |
Volume | |
Avg. volume | 47 |
Market cap | 29.612B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 30.31 |
EPS (TTM) | 1.94 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive.
DEERFIELD, Ill., May 13, 2024--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insuffici
Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 1st of July. This means the annual payment...